Hormonal control of growth and progression in tumors of Nb rats and a theory of action
- PMID: 830424
Hormonal control of growth and progression in tumors of Nb rats and a theory of action
Abstract
A continuation of previous studies of hormone-dependent tumors in various organs in Nb rats concerns the effects of removal of the hormone stimulus from animals with growing tumors. Tumor regression usually followed this procedure, and in various models it was associated with an increased survival of the animal. A regressed tumor could be caused to grow at any time by estrogen treatment, and the resulting tumor remained hormone dependent, although some progression might occur. Continuous breeding rarely affected the growth or progression of transplanted adrenal or breast carcinomas. When spontaneous regrowth of tumors took place following removal of the estrogen stimulus all types of tumors (except leiomyomas of the uterus, showed progression usually to autonomy, and in the case of male rats bearing breast carcinomas it was inevitable. The substitution of pellets containing a reduced level of estrone to determine which prevented regression and allowed uninterrupted growth offered an assessment of the type or amount of hormone required for the growth of different tumors. By means of such a model of breast cancer in male rats, it was possible to demonstrate that a reduction in hormone levels sufficient to prevent advancing tumor growth, but adequate to reduce the extent of regression, also reduced the frequency or prevented the development of autonomous change. Although regression per se was not a prerequisite for autonomous change, the paradox was evident that progression towards autonomous growth was accelerated with procedures expected to check tumor growth and was minimal with procedures that accelerated it. Liver metastases of hormone-dependent adrenal carcinomas continued growth and could not be influenced by removal of estrogen, although the primary transplant regressed. When such metastases were transplanted, they were not found to have progressed to autonomy but retained a hormone-dependent status. Some tumors, when maintained in estrogen-conditioned hosts, apparently showed a reversion to a more hormone-dependent cell type rather than the expected progression towards autonomy. A theory is suggested to explain the experiments findings on the development and control of estrogen-responsive tumors.
PIP: The effect of the removal of estrogen stimulus on the growth and progression of hormone-dependent tumors in various organs in Nb strain rats was investigated. Withdrawal of estrogen usually brought about regression of the tumor and, in some cases, an increased survival period. However, resumption of treatment caused a hormone-dependent growth of any regressed tumor, though progression was observed in some cases. In cases of spontaneous regrowth, all types of tumors, excepting leiomyomas of the uterus, showed progression and usually became autonomous. In experiments with pellets containing a reduced level of estrone, it was possible to prevent advancing tumor growth yet reduce the extent of regression, and at the same time reduce the frequency or prevent the development of autonomous change. Paradoxically, progression toward autonomous growth was stimulated by regimes expected to halt tumor growth and minimized by procedures that were expected to stimulate it. Transplanted liver metastases of hormone-dependent adrenal carcinomas retained their hormone dependence, even though the donor metastases continued growth despite removal of estrogen influence. A theory is offered to explain the results.
Similar articles
-
A classification of transplantable tumors in Nb rats controlled by estrogen from dormancy to autonomy.Cancer Res. 1975 Nov;35(11 Pt 1):2935-41. Cancer Res. 1975. PMID: 1182686
-
Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation.Cancer Res. 1975 Mar;35(3):766-80. Cancer Res. 1975. PMID: 1167809
-
Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen.Cancer Res. 1980 Oct;40(10):3547-50. Cancer Res. 1980. PMID: 7438041
-
Growth, morphology, and function of xenotransplanted human tumors.Pathol Annu. 1979;14 Pt 2:215-57. Pathol Annu. 1979. PMID: 94941 Review.
-
Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).Anticancer Res. 1983 Jul-Aug;3(4):273-81. Anticancer Res. 1983. PMID: 6309070 Review.
Cited by
-
Patient-Clinician choice in palliation of metastatic prostate cancer.Drugs Aging. 2000 Nov;17(5):331-7. doi: 10.2165/00002512-200017050-00001. Drugs Aging. 2000. PMID: 11190414 Review.
-
Mathematically modelling and controlling prostate cancer under intermittent hormone therapy.Asian J Androl. 2012 Mar;14(2):270-7. doi: 10.1038/aja.2011.155. Epub 2012 Jan 9. Asian J Androl. 2012. PMID: 22231293 Free PMC article. Review.
-
Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study.Clin Transl Oncol. 2017 Mar;19(3):373-378. doi: 10.1007/s12094-016-1538-5. Epub 2016 Oct 21. Clin Transl Oncol. 2017. PMID: 27770397 Clinical Trial.
-
Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.World J Surg. 1985 Oct;9(5):765-74. doi: 10.1007/BF01655192. World J Surg. 1985. PMID: 4060747 Clinical Trial. No abstract available.
-
Fr-MLV infection induces erythroleukaemia instead of lymphoid leukaemia in mice given pituitary grafts.Br J Cancer. 1990 Jun;61(6):841-5. doi: 10.1038/bjc.1990.188. Br J Cancer. 1990. PMID: 2372485 Free PMC article.